Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124599722 | 12459972 | 2 | F | 201604 | 20160722 | 20160613 | 20160809 | PER | US-PFIZER INC-2016264449 | PFIZER | 57.00 | YR | F | Y | 103.00000 | KG | 20160809 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124599722 | 12459972 | 1 | PS | GABAPENTIN. | GABAPENTIN | 1 | UNK, 2X/DAY (MORNING AND NIGHT) | N | 20235 | BID | |||||||||
| 124599722 | 12459972 | 2 | SS | GABAPENTIN. | GABAPENTIN | 1 | N | 20235 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124599722 | 12459972 | 1 | Neuropathy peripheral |
| 124599722 | 12459972 | 2 | Pain in extremity |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124599722 | 12459972 | Condition aggravated | |
| 124599722 | 12459972 | Drug ineffective for unapproved indication | |
| 124599722 | 12459972 | Hypoaesthesia | |
| 124599722 | 12459972 | Pain in extremity | |
| 124599722 | 12459972 | Paraesthesia | |
| 124599722 | 12459972 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124599722 | 12459972 | 1 | 201604 | 0 |